The current NBIX market cap is 13.72B. The company's latest EPS is USD 2.5094 and P/E is 54.96.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 387.9M | 412M | 420.4M | 452.7M | 498.8M |
Operating Income | 87.8M | 103.4M | -114.2M | 73.6M | 141.2M |
Net Income | 68.5M | 89M | -76.6M | 95.5M | 83.1M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 788.09M | 1.05B | 1.13B | 1.49B | 1.89B |
Operating Income | 72.28M | 163M | 102.5M | 249M | 250.9M |
Net Income | 37.01M | 407.3M | 89.6M | 154.5M | 249.7M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 2.14B | 2.37B | 2.36B | 2.61B | 2.85B |
Total Liabilities | 598.8M | 660.9M | 675.3M | 760.1M | 846.1M |
Total Equity | 1.54B | 1.71B | 1.68B | 1.85B | 2B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.31B | 1.73B | 2.07B | 2.37B | 3.25B |
Total Liabilities | 669.12M | 608.5M | 698.5M | 660.9M | 1.02B |
Total Equity | 636.92M | 1.13B | 1.37B | 1.71B | 2.23B |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 196.4M | 339.4M | -125.2M | 54.4M | 266.4M |
Investing | -61.5M | -177.1M | -42.1M | -168M | -265.3M |
Financing | -258.9M | -234.3M | 8.2M | 11.1M | 29.9M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 152.05M | 228.5M | 256.5M | 339.4M | 389.9M |
Investing | -211.07M | 4.1M | -130.2M | -177.1M | -467.1M |
Financing | 27.31M | -157.8M | 27.4M | -234.3M | 65.3M |
Market Cap | 13.72B |
Price to Earnings Ratio | 54.96 |
Price to Sales Ratio | 7.27 |
Price to Cash Ratio | 54.65 |
Price to Book Ratio | 6.15 |
Dividend Yield | - |
Shares Outstanding | 99.51M |
Average Volume (1 week) | 1.15M |
Average Volume (1 Month) | 1.02M |
52 Week Change | 42.44% |
52 Week High | 148.3699 |
52 Week Low | 89.04 |
Spread (Intraday) | 6.5 (4.61%) |
Company Name | Neurocrine Biosciences Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.neurocrine.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.